Back to Trades
Sullivan Timothy Eugene
InsiderCIK 0001707000
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Sullivan Timothy Eugene accounts for 7 disclosed filings worth $19.6M, all concentrated in Apellis Pharmaceuticals, Inc. (APLS), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $1.8M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| May 14 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Insider | Grant | $17.3M |
| Apr 20 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Insider | Gift | $0 |
| Jan 23 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $223.9K |
| Jan 21 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $57.2K |
| Jan 15 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $85.6K |
| Oct 23 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $280.3K |
| Sep 10 | APLS Apellis Pharmaceuticals, Inc. | Sullivan Timothy Eugene | Chief Financial Officer | Sell | $1.2M |
7 filings